FluoroPharma nets $1.6M in financing

AuntMinnie.com staff writers
Jun 23, 2011

Imaging agent developer FluoroPharma Medical has completed $1.6 million in financing to advance its portfolio of PET imaging agents currently under development.

The money adds to $5.3 million in financing the company received in May.

Latest in Molecular Imaging
2025 04 07 Pet Music Thumbnail
PET reveals brain’s responses to music
April 7, 2025
Imaging Life Issue 20 now available
Sponsored
Imaging Life Issue 20 now available
April 1, 2025
Attr Thumbnail
SPECT/CT measure validated for diagnosing ATTR
April 4, 2025
Heart Plaque
CAC score of 0 indicate low heart event risk, even in older people
March 29, 2025
Related Stories
2011 06 17 17 43 35 704 Molec Insider Thumb
Nuclear Medicine
Treadmill stress tests don't compromise follow-up FDG-PET
2011 06 13 15 21 27 302 Pet Fddnp Images Thumb
Nuclear Medicine
PET tracks amyloid plaques, tangles in Down syndrome
2011 06 13 09 36 58 905 Segall George 150
Nuclear Medicine
Segall elected SNM president
Imaging Life Issue 20 now available
Sponsor Content
Imaging Life Issue 20 now available
More in Molecular Imaging
PET reveals brain’s responses to music
By Will Morton
PET has provided the first neuroimaging evidence that music affects the brain’s opioid receptor system.
April 7, 2025
2025 04 07 Pet Music Thumbnail
China limits exports of rare earth elements, targets CT x-ray tubes
By Erik L. Ridley
China's Ministry of Commerce has announced export controls for several rare earth elements and launched investigations of imported CT x-ray tubes.
April 4, 2025
China Flag
SPECT/CT measure validated for diagnosing ATTR
By Will Morton
A research team in Finland has validated the accuracy of a SPECT/CT measure for diagnosing transthyretin amyloidosis.
April 4, 2025
Attr Thumbnail
CAC score of 0 indicate low heart event risk, even in older people
By Kate Madden Yee
PET/CT imaging indicates that a coronary artery calcium (CAC) score of 0 is an accurate indicator of low coronary heart event risk even as a person ages, investigators have reported.
March 29, 2025
Heart Plaque
PET/CT visualizes extremely rare brain inflammation
By Will Morton
An F-18 FDG-PET/CT scan proved crucial in identifying an ultrarare case of brain inflammation in a patient due to the flu.
March 27, 2025
Brain MRI and F-18 FDG brain and whole-body PET/CT images. (A) No obvious abnormalities were found in axial and sagittal slices from T2-weighted MR images. (B) Whole cerebellar cortex had diffuse F-18 FDG hypermetabolism in PET/CT brain images, with SUVmax of 25.91. (C and D) Whole-body F-18 FDG-PET/CT showing distended bladder. TLG = total lesion glycolysis; MTV = metabolic tumor volume. Image and caption courtesy of the Journal of Nuclear Medicine.
Targeted alpha therapy’s ‘elite 8’ radionuclides
By Will Morton
A select group of eight radionuclides holds hopes for an emerging cancer treatment in nuclear medicine called targeted alpha therapy (TAT).
March 26, 2025
Isotopes1
Loading Most Popular Stories...
New method proposed for diagnosing Alzheimer’s
By Will Morton
Researchers in Germany have proposed a new approach derived from brain PET imaging for diagnosing and staging Alzheimer’s disease.
March 25, 2025
2025 03 25 Fill States Thumbnail
Whole-body PET visualizes COVID-19 infection
By Will Morton
Researchers in France have developed a PET imaging approach for longitudinal tracking of the virus that causes COVID-19.
March 24, 2025
2025 03 24 Covid Brain Thumbnail
PSMA PET/CT identifies 'atypical' metastases in prostate cancer patients
By Will Morton
PET/CT scans with an experimental PSMA imaging agent can identify supraclavicular nodal metastasis in newly diagnosed prostate cancer patients.
March 21, 2025
F-18 PSMA-1007 PET/CT of a 70 year old with newly diagnosed prostate cancer: PSA 770 ng/ml; Gleason 5 + 5; International Society of Urological Pathology grade 5. The maximum intensity projection images, CT, and fused images show PSMA ligand-avid prostate primary with pelvic, retroperitoneal, and mediastinal nodal spread. Additionally, he had left supraclavicular nodal metastasis (arrows). Image and caption available for republishing under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0 International) and courtesy of EJNMMI Reports.
IAEA touts radionuclide development activities
By Will Morton
The IAEA has highlighted its worldwide activities to meet increasing demands for alpha-emitting radionuclides for use in Targeted Alpha Therapy.
March 18, 2025
Isotopes1
FAPI-PET superior to FDG-PET for detecting bone cancer
By Will Morton
PET/CT imaging with fibroblast activation protein inhibitor (FAPI) detects more bone metastases than FDG-PET/CT in patients with different types of cancer.
March 17, 2025
Cancer Cell Target2
New analysis supports use of FES-PET in breast cancer patients
By Will Morton
F-18 fluoroestradiol (FES)-PET scans can predict whether endocrine therapy could be effective in women with estrogen receptor-positive breast cancer.
March 13, 2025
Fes Pet Abstract Thumbnail
Page 1 of 602
Next Page